<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01268189</url>
  </required_header>
  <id_info>
    <org_study_id>H-09-008</org_study_id>
    <nct_id>NCT01268189</nct_id>
  </id_info>
  <brief_title>Evaluation of Oxygen Diffusion Dressing for Accelerating Healing of Donor Site and Other Wounds</brief_title>
  <official_title>Evaluation of Oxygen Diffusion Dressing for Accelerating Healing of Donor Site and Other Wounds</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>United States Army Institute of Surgical Research</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>United States Army Institute of Surgical Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single-center, prospective, randomized, and controlled study to evaluate the
      effectiveness of OxyBand Dressing for the use as a dressing for autogenous skin donor sites
      compared to our current standard donor site dressing (Xeroform). Hypothesis is that the mean
      healing time for wounds treated with the OxyBand dressing will be less than the mean healing
      time for wounds treated with the Xeroform dressing.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who are scheduled for excision of burns or other injuries will have one of two donor
      sites covered with the OxyBand Dressing, and the other treated according to standard of care.
      OxyBand is an FDA (Food and Drug Administration) approved (K043063) wound dressing for
      delivery of oxygen into the wound. Two small clinical studies using OxyBand have been
      conducted on standardized laser burn wounds, demonstrating faster healing time compared to a
      placebo. No studies have compared this dressing to Xeroform dressing, the standard dressing
      used on donor sites in the USAISR.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Healing Time for Donor Site Wounds</measure>
    <time_frame>number of days to healing</time_frame>
    <description>Wounds are inspected on postoperative days 4, 8, and then every two days until the wound is deemed to be healed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Perceived by Patient</measure>
    <time_frame>Post-Operative Day 4</time_frame>
    <description>Patient will be asked to rate pain 0-10 (0=no pain, 10=maximum pain) at the study site and the control site. Used Visual Analogue Scale (VAS) for this purpose.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Will be Asked to Rate Pain 0-10/10 at the Study Site and the Control Site</measure>
    <time_frame>Post-Operative Day 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Will be Asked to Rate Pain 0-10/10 at the Study Site and the Control Site</measure>
    <time_frame>Post-Operative Day 10</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Will be Asked to Rate Pain 0-10/10 at the Study Site and the Control Site</measure>
    <time_frame>Post-Operative Day 12</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>Burn wound patients with donor sites</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oxygen diffusing dressing applied to wound vs standard of care dressing (Xeroform) applied to wound (patient serves as own control as s/he receives 1 dressing on 1 donor site and the other on a 2nd donor site)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Oxygen diffusing dressing</intervention_name>
    <description>Oxygen diffusing dressing applied to study wound</description>
    <arm_group_label>Burn wound patients with donor sites</arm_group_label>
    <other_name>OxyBand dressing</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard of care dressing</intervention_name>
    <description>Xeroform control dressing applied to control wound</description>
    <arm_group_label>Burn wound patients with donor sites</arm_group_label>
    <other_name>Xeroform dressing</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must be at least 18 years of age; of either gender and in good general health.

          -  Subject has sustained burn wounds of less than 30 percent of the total body surface
             area

          -  Burn wounds do not involve the harvesting area

          -  Subject has sustained burn wounds that, in the judgment of the attending surgeon,
             require excision and grafting of sufficient extent to justify two donor sites of equal
             and symmetrical size on non-dependent body surfaces areas

          -  The scheduled excision and grafting procedure is the first such operation for the
             subject during this hospitalization

          -  Subject agrees to participate in follow-up evaluations

        Exclusion Criteria:

          -  Critical illnesses such as those requiring ventilator support, or having a systemic
             infection or hemodynamic instability, defined as a mean arterial pressure less than 60
             or requiring vasoactive medications to support blood pressure

          -  Major acute or chronic medical illnesses that could affect wound healing (e.g.
             peripheral vascular disease, insulin dependent diabetes, blood clotting disorder)

          -  Subjects receiving treatment with medications that inhibit or compromise wound
             healing. Examples include therapeutic anticoagulants, antiplatelet drugs, and systemic
             steroids such as warfarin, clopidogrel or prednisone. The use of anticoagulants does
             not include DVT (Deep Vein Thrombosis) prophylaxis. Subjects may use aspirin or
             lovenox

          -  Cellulitis or other infection of the potential donor sites

          -  Donor site has been previously harvested for grafting

          -  Subjects with greater than 30% total body surface area burns

          -  Pregnancy

          -  Prisoners
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kimberly F Lairet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>US Army Institute of Surgical Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>US Army Institute of Surgical Research, Burn Center</name>
      <address>
        <city>Ft. Sam Houston</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2010</study_first_submitted>
  <study_first_submitted_qc>December 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2010</study_first_posted>
  <results_first_submitted>December 10, 2013</results_first_submitted>
  <results_first_submitted_qc>September 8, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 9, 2015</results_first_posted>
  <last_update_submitted>September 8, 2015</last_update_submitted>
  <last_update_submitted_qc>September 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>burn wound</keyword>
  <keyword>management with oxygen</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Burn Wound Patients</title>
          <description>Burn wound patients with experimental (oxyband) and control (Xeroform) dressings placed on 2 separate skin graft donor sites</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Subjects serve as their own control as experimental and standard of care dressings applied to 2 different donor sites. Total of 17 participants completed, with 34 donor sites.</population>
      <group_list>
        <group group_id="B1">
          <title>Burn Wound Patients</title>
          <description>Burn wound patients with oxygen diffusing dressing placed on 1 donor skin graft site and standard of care (Xeroform) dressing placed on a 2nd donor skin graft</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35" lower_limit="20" upper_limit="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Burn Size</title>
          <units>percentage of total skin area</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.2" lower_limit="2" upper_limit="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Healing Time for Donor Site Wounds</title>
        <description>Wounds are inspected on postoperative days 4, 8, and then every two days until the wound is deemed to be healed.</description>
        <time_frame>number of days to healing</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Study Dressing</title>
            <description>Oxygen diffusing dressing applied to wound
Oxygen diffusing dressing: Oxygen diffusing dressing applied to study wound</description>
          </group>
          <group group_id="O2">
            <title>Control Dressing</title>
            <description>Xeroform (current standard of care) dressing applied to wound
Control dressing: Xeroform control dressing applied to control wound</description>
          </group>
        </group_list>
        <measure>
          <title>Healing Time for Donor Site Wounds</title>
          <description>Wounds are inspected on postoperative days 4, 8, and then every two days until the wound is deemed to be healed.</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.4" spread="1.7"/>
                    <measurement group_id="O2" value="12.4" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Perceived by Patient</title>
        <description>Patient will be asked to rate pain 0-10 (0=no pain, 10=maximum pain) at the study site and the control site. Used Visual Analogue Scale (VAS) for this purpose.</description>
        <time_frame>Post-Operative Day 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Study Dressing</title>
            <description>Oxygen diffusing dressing applied to wound
Oxygen diffusing dressing: Oxygen diffusing dressing applied to study wound</description>
          </group>
          <group group_id="O2">
            <title>Control Dressing</title>
            <description>Xeroform (current standard of care) dressing applied to wound
Control dressing: Xeroform control dressing applied to control wound</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Perceived by Patient</title>
          <description>Patient will be asked to rate pain 0-10 (0=no pain, 10=maximum pain) at the study site and the control site. Used Visual Analogue Scale (VAS) for this purpose.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="1.6"/>
                    <measurement group_id="O2" value="1.6" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Will be Asked to Rate Pain 0-10/10 at the Study Site and the Control Site</title>
        <time_frame>Post-Operative Day 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Study Dressing</title>
            <description>Oxygen diffusing dressing applied to wound
Oxygen diffusing dressing: Oxygen diffusing dressing applied to study wound</description>
          </group>
          <group group_id="O2">
            <title>Control Dressing</title>
            <description>Xeroform (current standard of care) dressing applied to wound
Control dressing: Xeroform control dressing applied to control wound</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Will be Asked to Rate Pain 0-10/10 at the Study Site and the Control Site</title>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="1.3"/>
                    <measurement group_id="O2" value="1.4" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Will be Asked to Rate Pain 0-10/10 at the Study Site and the Control Site</title>
        <time_frame>Post-Operative Day 10</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Study Dressing</title>
            <description>Oxygen diffusing dressing applied to wound
Oxygen diffusing dressing: Oxygen diffusing dressing applied to study wound</description>
          </group>
          <group group_id="O2">
            <title>Control Dressing</title>
            <description>Xeroform (current standard of care) dressing applied to wound
Control dressing: Xeroform control dressing applied to control wound</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Will be Asked to Rate Pain 0-10/10 at the Study Site and the Control Site</title>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="1"/>
                    <measurement group_id="O2" value="0.8" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Will be Asked to Rate Pain 0-10/10 at the Study Site and the Control Site</title>
        <time_frame>Post-Operative Day 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Study Dressing</title>
            <description>Oxygen diffusing dressing applied to wound
Oxygen diffusing dressing: Oxygen diffusing dressing applied to study wound</description>
          </group>
          <group group_id="O2">
            <title>Control Dressing</title>
            <description>Xeroform (current standard of care) dressing applied to wound
Control dressing: Xeroform control dressing applied to control wound</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Will be Asked to Rate Pain 0-10/10 at the Study Site and the Control Site</title>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.8"/>
                    <measurement group_id="O2" value="0.5" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Study Dressing</title>
          <description>Oxygen diffusing dressing applied to wound
Oxygen diffusing dressing: Oxygen diffusing dressing applied to study wound</description>
        </group>
        <group group_id="E2">
          <title>Control Dressing</title>
          <description>Xeroform (current standard of care) dressing applied to wound
Control dressing: Xeroform control dressing applied to control wound</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Blistering</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="17"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Leopoldo C. Cancio, COL, MC</name_or_title>
      <organization>USAISR</organization>
      <phone>210-916-3301</phone>
      <email>leopoldo.c.cancio.mil@mail.mil</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

